...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
【24h】

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.

机译:与赖诺普利相比,硝苯地平治疗的高血压肾移植受者的肾移植功能持续改善了两年。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Treatment of posttransplant hypertension is still a matter of debate. Calcium antagonists may ameliorate renal side effects of cyclosporin. Angiotensin converting enzyme- (ACE) inhibitors may be more effective in sustaining renal function in native chronic renal disease. We prospectively compared the effect of controlled release nifedipine and lisinopril on long-term renal function in hypertensive kidney transplant patients treated with cyclosporin. METHODS: A total of 154 renal transplant patients presenting with hypertension (diastolic blood pressure >or=95 mmHg) during the first 3 weeks after transplantation were randomised to receive double-blind nifedipine 30 mg or lisinopril 10 mg once daily. A total of 123 patients completed 1 year of treatment (69 nifedipine, 54 lisinopril) and 64 patients completed 2 years of double-blind treatment (39 nifedipine, 25 lisinopril). Baseline glomerular filtration rate was measured as 99 mTc-diethylene-triaminepentaacetate clearance in a stable phase 2 to 5 weeks after inclusion and repeated at 1 and 2 years. RESULTS: Baseline glomerular filtration rates were similar (46+/-16 ml/min with nifedipine, 43+/-14 ml/min with lisinopril). The changes in glomerular filtration rates from baseline were statistically significant between the groups after 1 year (9.6 ml/min mean treatment difference (95% confidence interval [CI]s 5.5-13.7 ml/min, P=0.0001) and remained statistically significant also after 2 years (10.3 ml/min mean difference (95% CIs 4.0-16.6], P=0.0017). After 1 year glomerular filtration rates averaged 56+/-19 ml/min in the nifedipine group and 44+/-14 ml/min in the lisinopril group. CONCLUSIONS: Both nifedipine and lisinopril were safe and effective in treatment of hypertension in renal transplant patients treated with cyclosporin. Patients receiving nifedipine but not lisinopril improved kidney transplant function over a period of 2 years.
机译:背景:移植后高血压的治疗仍是一个争论的问题。钙拮抗剂可以改善环孢菌素的肾脏副作用。血管紧张素转化酶-(ACE)抑制剂在维持天然慢性肾脏疾病中的肾功能方面可能更有效。我们前瞻性比较了环孢素治疗的高血压肾脏移植患者中控释硝苯地平和赖诺普利对长期肾功能的影响。方法:总共154例肾移植患者在移植后的前3周内出现高血压(舒张压>或= 95 mmHg),随机接受双盲硝苯地平30 mg或赖诺普利10 mg每天一次。共有123名患者完成了1年的治疗(69硝苯地平,54赖诺普利),64例患者完成了2年的双盲治疗(39硝苯地平,25赖诺普利)。基线肾小球滤过率测定为纳入后2至5周在稳定期中99 mTc-二亚乙基三胺五乙酸盐的清除率,并在1年和2年重复。结果:基线肾小球滤过率相似(硝苯地平为46 +/- 16 ml / min,赖诺普利为43 +/- 14 ml / min)。一年后,两组之间的肾小球滤过率相对于基线的变化具有统计学意义(9.6 ml / min的平均治疗差异(95%置信区间[CI] s 5.5-13.7 ml / min,P = 0.0001)),并且在统计学上也很显着2年后(10.3 ml / min的平均差异(95%CIs 4.0-16.6],P = 0.0017)。一年后,硝苯地平组的肾小球滤过率平均为56 +/- 19 ml / min,而硝苯地平组平均为44 +/- 14 ml结论:硝苯地平和赖诺普利均能安全有效地治疗环孢素治疗的肾移植患者的高血压;接受硝苯地平但未使用赖诺普利的患者可在2年内改善肾脏移植功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号